HK Stock Market Move | KINTOR PHARMA-B (09939) falls by over 9%, the battle for the "strongest on the surface" whitening ingredient continues.

KINTOR PHARMA-B(09939) plunged more than 9%, with its stock price dropping nearly 35% over the past three trading days. As of the time of writing, it fell 9% to HK$2.73, with a turnover of HK$7.5153 million. On the news front, the recent business war between the German beauty giant Beiersdorf and Kaituo Pharmaceutical over the "strongest whitening ingredient on the surface of the earth" continues to escalate. In the early hours of March 21, Beiersdorf released a statement through its official WeChat public account titled "Science needs 'collisions', not 'porcelain collisions'", in which, in addition to detailing the research and development mechanism and scientific basis of TIANMINGDUO 630, it once again mentioned "Suzhou Kaituo KT-939". Beiersdorf pointed out that it had noticed "written opinions and search reports issued by the National Intellectual Property Office on Suzhou Kaituo KT939 related patent applications. According to public information, after comparing the cited existing technologies, the report made a negative evaluation of the novelty and creativity of its main claims." In response, Kaituo Pharmaceutical stated on March 22 that Beiersdorf's statement will not change the direction of our product commercialization. The company has always believed that commercial disputes should return to facts and laws. Comply with patent law, comply with commercial law, and in the face of the law, every company is equal, and the standards of lawful operation are consistent for both multinational corporations and small businesses. The public opinion war can come to an end. Due to Beiersdorf's two statements causing serious damage to the company's stock price and the reputation of the KT-939 product, we will also resolutely protect our legitimate rights in accordance with the law to safeguard the innovative achievements of entrepreneurial companies from infringement.